Study protocol for “MDMA-assisted therapy as a treatment for major depressive disorder
A proof of principle study”
Bibliographic Data
| ID | 15525787 |
|---|---|
| Authors | Tor-Morten Kvam (0000-0002-3354-1511, University of Oslo, corresponding author), Ivar W Goksøyr (0009-0001-7656-625X, Østfold Hospital Trust), Louis H Stewart (0000-0002-8429-2869, Østfold Hospital Trust), Lowan H Stewart, Dimitris Repantis (0000-0001-5130-6286, Charité - Universitätsmedizin Berlin), Jan Ivar Røssberg (0000-0003-4115-9133, Oslo University Hospital), Ole A Andreassen (0000-0002-4461-3568, Oslo University Hospital) |
| Year | 2022 |
| Volume | 13 |
| Pages | 954388-954388 |
| Publication date | 2022-10-26 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Psychiatry (JOURNAL) |
| Journal identifiers | ISSN: 1664-0640 • E-ISSN: 1664-0640 |
| Publisher | Frontiers Media (PUBLISHER • CH) |
| DOI | 10.3389/fpsyt.2022.954388 |
| PMID | 36386973 |
| OpenAlex | W4307553648 |
| Language | EN |
| References cited | 51 |
EudraCT number 2021-000805-26
Adverse effect · Alternative medicine · Clinical Global Impression · Clinical trial · Cognition · Dosing · Major depressive disorder · MDMA · Psychiatry · Cannabis and Cannabinoid Research · Medicine · Psychedelics and Drug Studies · Psychology · Tryptophan and brain disorders · Internal Medicine
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer
Comparison of Beck Depression Inventories-IA and-II in Psychiatric Outpatients
A New Depression Scale Designed to be Sensitive to Change
MDMA-assisted therapy for severe PTSD
Psychotherapy for depression in adults
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer
Oxytocin increases trust in humans
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder
The role of specific early trauma in adult depression
Evaluation of the Drug Use Disorders Identification Test (Dudit) in Criminal Justice and Detoxification Settings and in a Swedish Population Sample
A Meta-Analysis of Cognitive-Behavioural Therapy for Adult Depression, Alone and in Comparison with other Treatments
Psilocybin with psychological support for treatment-resistant depression
Trial of Psilocybin versus Escitalopram for Depression
The Warwick-Edinburgh Mental Well-being Scale (WEMWBS)
The twenty-item Toronto Alexithymia scale—I. Item selection and cross-validation of the factor structure
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
Acute Psychological and Neurophysiological Effects of MDMA in Humans
Subjective Reports of the Effects of MDMA in a Clinical Setting
Perceived Benefits of MDMA-Assisted Psychotherapy beyond Symptom Reduction
Development of the Alcohol Use Disorders Identification Test (Audit)
The Development and Validation of a Scale to Measure Self-Compassion
| Highly cited | No |
|---|